Royalty Pharma Stock News

NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at Cowen’s 42 nd Annual Health Care Conference on March 8, 2022 at 11:10 a.m. ET.

NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at Cowen's 42nd Annual Health Care Conference on M

If history is any guide, there may be good fortune ahead for shares of Royalty Pharma (NASDAQ: RPRX ). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock. What To Know: Many traders use moving average crossover systems to make their decisions. When a shorter-term average price crosses above a longer-term average price, it could mean the stock is trending higher. If the short-term average price crosses … Full story available on Benzinga.com

RPRX earnings call for the period ending December 31, 2021.

Royalty Pharma press release (RPRX): Q4 consolidated net income of $54M.Revenue of $576M (+0.7% Y/Y) beats by $32.63M.Full Year 2022 guidance: Adjusted Cash Receipts of $2,225 to…

NEW YORK, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the fourth quarter and full year of 2021 and introduced 2022 Adjusted Cash Receipts ( 1) (a non-GAAP financial measure) guidance.

Royalty Pharma's (RPRX) CEO Pablo Legorreta on Q4 2021 Results - Earnings Call Transcript

Berkshire Bought Activision In Q4 Ahead Of Microsoft Purchase; Added To Chevron, Trimmed Visa, Mastercard And Pharma Stocks In the weeks before Microsoft made the surprise announcement it was acquiring the troubled Activision, the market was rife with speculation that Berkshire itself could make a play - no pun intended - for the foundering video game company whose stock had tumbled so much in the fourth quarter amid poor earnings and sexual harassment scandals, many viewed it as a deep value play suitable even for Warren Buffett. In retrospect, that didn''t pan out, but as we learned today after the quarterly 13F bonanza hit, Berkshire was buying Activision in Q4 when the stock was tumbling, and as of Dec 31, Berkshire owned 14.658 million shares of Activision stock, representing 1.9% of the shares outstanding. Assuming Buffett bought around the average price for the quarter, or $65, Berkshire made around $250 million on that purchase alone which is not a bad payout for a few weeks worth of work (one wonders if the information that Buffett was buying somehow leaked, and prompted Microsoft''s unexpected acquisition of ATVI).

Warren Buffett once again was a net seller of equities in the fourth quarter, slicing, slashing and outright exiting stakes across a series of sectors that have fallen out of his favor. But the Oracle

Royalty Pharma (NASDAQ:RPRX) is scheduled to announce Q4 earnings results on Tuesday, February 15th, before market open.The consensus EPS Estimate is $0.78 and the consensus…

Royalty Pharma (RPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Updated Guidance And Royalty Pharma Financing Demolish Short Thesis For BioCryst Pharmaceuticals

NEW YORK, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its fourth-quarter and full-year 2021 financial results on Tuesday, February 15, 2022